Endocrine Society Learning Center

Log-in / Create Account

Session Information

2010 Clinical Endocrinology Update

Click here to go to the previous page

Panel Q&A

Track : Friday October 1, 2010

Program Code: 280

Date: Friday, October 1, 2010

Time: 1:45 PM to 2:15 PM EST

Location: Los Angeles Room

SPEAKER (S):

Irl B. Hirsch, MD, Univ of Washington Med Ctr
Disclosure:Irl B. Hirsch, MD, has received research grant support from Novo Nordisk and MannKind; has received consultant fees from Bayer, Roche, Johnson & Johnson and Abbott.

Dr. Hirsch is a professor of medicine and holds the Diabetes Treatment and Teaching Chair at the University of Washington School of Medicine in Seattle. Dr. Hirsch went to medical school at the University of Missouri in Columbia, MO, completed his residency at Mt. Sinai Hospital in Miami Beach, FL, and trained as a research fellow at Washington University in St. Louis. Dr. Hirsch has been interested in new technologies for the treatment of diabetes, particularly those involved in the use of insulin therapy. He has also been interested in the mechanisms of how insulin co-modulates inflammation with glucose and how this results in improvements in outcomes, particularly of hospitalized patients. The management of hyperglycemia in the hospital has been an interest of Dr. Hirsch for over 25 years. He has been involved in numerous major clinical research trials, including the DCCT, ACCORD, STAR-1, JDRF Sensor Trial, SEARCH, ORIGIN, ADAG, and many more particularly involved with insulin therapy. He is interested in the use of computers in diabetes data management, and how pattern recognition can be used to improve diabetes control, in addition to how glycemic variability noted on glucose meter downloads may be an independent risk for microvascular complications. He has a very active clinical practice of which 80% of patients have type 1 diabetes. He has authored over 100 papers including a review of insulin in the New England Journal of Medicine, 40 editorials, numerous book chapters, and four books both for patients and physicians. He is the past editor-in-chief of DOC News and Clinical Diabetes. He is the formal chair the Professional Practice Committee for the American Diabetes Association and served as a member of the Endocrine Section of the American Board of Internal Medicine.

Kenneth Cusi, MD, Univ TX Hlth Sci Ctr San Antonio
Disclosure:Kenneth Cusi, MD, has received speakers bureau honoraria from Abbott, AstraZeneca and Merck; has received research grant support from Amylin, Eli Lilly and Takeda.

Dr. Kenneth Cusi received his medical degree and did his residency in Buenos Aires, Argentina. He moved to Houston, Texas, USA, where he completed a fellowship in Endocrinology, Diabetes and Metabolism at Baylor College of Medicine. Dr. Cusi is an Associate Professor in the Diabetes Division at the University of Texas Health Science Center at San Antonio, where he has worked for the past 12 years. He is the Director of the Endocrinology and Metabolism Clinic at the Veterans Administration Medical Center at San Antonio, Texas. Dr. Cusi has held grants from the NIH, Howard Hughes Institute and Veterans Administration. His work is aimed at understanding the mechanisms of insulin resistance and the associated abnormalities that cause cardiovascular disease, and a search for new pharmacological treatments for patients with type 2 diabetes and non-alcoholic fatty liver disease (NAFLD) and steatohepatits (NASH). He is a Board member of the National Lipid Association (Southwest Chapter) and of the Metabolism Section of the American Diabetes Association Annual Scientific 2007 Organizing Committee. He is a fellow of the American College of Physicians and of the American Association of Clinical Endocrinologists (AACE). He is a board member for the AACE Minority Health Affairs Committee and the Steering Committee for the Texas Chapter of AACE. He has published in many peer-reviewed journals such as New England Journal of Medicine, Proceeding of the National Academy of Science, Journal of Clinical Investigation, Diabetes, Diabetes Care, Diabetes Reviews, The Endocrinologist, Journal of Clinical Endocrinology and Metabolism, and the American Journal of Physiology (among others), and is a reviewer for several journals in the fields of endocrinology, diabetes and cardiovascular disease.

Description

Panel Q&A

Audio Synchronized to PowerPoint

(Code: 280)

This session is a part of:

Complete Clinical Endocrinology Update Compilation